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Abstract
Despite an abundance of evidence illustrating the harmful effects of nicotine use, only a small
percentage of users successfully quit (Messer et al., 2008). Moreover, current treatments for
nicotine cessation produce only a slight increase in the likelihood of successfully quitting, which
emphasizes the need for more effective strategies that facilitate smoking cessation (Hopkins et
al., 2001). Several studies suggest that difficulty in controlling nicotine use behaviors results
from nicotine’s ability to enhance the motivating function of cues associated with obtaining
rewards. These studies indicate that it is of value to understand the behavioral and
neuropharmacological mechanisms by which nicotine enhances responding for conditioned
rewards. Unfortunately, despite ample non-human studies, there is a paucity of literature
examining nicotine’s ability to enhance reward responding in humans. Thus, in order to better
understand the reward mechanisms that underlie the risk for becoming dependent, the aim of the
current study was to examine nicotine’s effects on conditioning, extinction, and reinstatement in
humans. Using a novel virtual reality translation of the hallmark conditioned place preference
paradigm to investigate the aforementioned objectives, our main findings suggest that nicotine
(1) increases the sensitivity of reward properties by enhancing the strength of food-reward
conditioning, (2) delays the rate of extinction of conditioned preferences, and (3) increases the
reinstatement of previous conditioning. These findings demonstrate the efficacy of utilizing the
virtual conditioned place preference paradigm in understanding the behavioral mechanisms by
which nicotine enhances responding for conditioned rewards, and provide insight into how
nicotine can be particularly resistant to treatment. Importantly, these data provide key
information for future work aimed at increasing the understanding of how conditioning
paradigms can help treat and prevent substance dependences.

vi

Chapter 1: General Introduction
Nicotine dependence has been shown to result in devastating health problems, including
heart disease, lung disease, and cancer, as well as an increased susceptibility to a variety of
infectious diseases (Benowitz, 2009). Despite the risks associated with its use, 17.8% of United
States adults aged 18 years or older currently smoke cigarettes (CDC, 2014). Although 68.8% of
U.S. tobacco users reported in 2010 that they wanted to quit completely (CDC, 2014), it is
estimated that 80% of smokers who attempt to quit on their own relapse within the first month of
abstinence, and approximately 3% remain abstinent at six months (CDC, 2000). This illustrates
the severity of nicotine dependence and the chronic nature of the disorder. While most of the
toxicity of nicotine use is related to the added components of nicotine-containing products (i.e.
cigarettes, cigars, snuff, and chewing tobacco), the pharmacologic effects of nicotine are
primarily responsible for the production and maintenance of the dependence (Benowitz, 2009).
Thus, an understanding of how nicotine produces dependence and influences usage provides a
necessary foundation for optimal nicotine use prevention and treatment therapies.

Motivational factors that contribute to nicotine use
Acute pharmacological effects of nicotine on motivational states, like the relief of anxiety
or stress and the induction of euphoria, are likely responsible for initial experimental nicotine
use. Like other psychomotor stimulants, nicotine dependence has been associated with the drug’s
ability to produce subjective sensations that can be described as a “rush,” “elation,” or “buzz”
(Baker et al., 2004). Studies indicate that nicotine exerts anxiolytic and mood-enhancing effects
(Leventhal, 2010), and beneficially influences neural processing of affective information
(Kobiella et al, 2014). The expectation that nicotine will produce positive emotional
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consequences has been shown to predict urges to smoke during the course of ongoing smoking
(Zinser et al. 1992), and has been shown to inversely predict cessation success (Wetter et al.,
1994). In addition to mood-enhancement, nicotine has also been shown to significantly improve
cognitive performance in terms of attention and working memory function (Rezvani and Levin,
2002); however, Heishman et al. (1999) argues that enhanced attention and cognition are
unlikely to play a major role in the decision to begin or to continue smoking.
However, while the positively reinforcing effects of mood enhancement by nicotine
administration seem to play an important role in nicotine use behavior, an accumulating literature
implicates a greater role for negative reinforcement in nicotine dependence. For example,
although positive affect imagery elicits smoking urges, it is less effective than negative affect
imagery (Tiffany & Drobes, 1990). Smokers reliably report that they smoke more when they are
stressed, angry, anxious, or sad (Ikard et al., 1969), and hold the expectation that smoking will
alleviate such negative mood states (Baker et al., 2004). Numerous studies have also found a
positive relationship between stress and increased cravings for nicotine (Childs & de Wit, 2010),
as well as increases in the rate and intensity of smoking intake (Payne, 1991). Subjective selfreports of stress reduction from nicotine use are not uncommon, where several studies have
revealed that smoking attenuates subjective stress not only in anticipation of a stressor, but in the
direct presence of a stressor as well (Kassel et al., 2003). These stressors have included aversive
noises (Woodson et al., 1986), viewing stressful imagery (Gilbert et al., 1989), and engaging in a
public speaking procedure (Juliano & Brandon, 2002). In addition to demonstrating that levels of
negative affect strongly influence cessation outcome, negative affect is also a factor of nicotine
withdrawal that significantly predicts relapse (Cinciripini et al., 2003).
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Some withdrawal symptoms in humans have been shown to manifest for up to 10 weeks
following nicotine cessation (Hughes, 1992); however, averaged across individuals, these
symptoms are typically observed to increase sharply during the first week of cessation and
decrease to baseline values within 4 weeks (Cummings et al., 1985). Nicotine cessation and
withdrawal produce a number of undesirable effects. In humans, acute nicotine withdrawal is
characterized by somatic symptoms, such as bradycardia, gastrointestinal discomfort, and
increased appetite leading to weight gain (Heishman, 1994), as well as affective symptoms like
negative changes in mood (Hall et al., 2015), dysphoria, irritability, anxiety, frustration,
increased reactivity to environmental stimuli (Hughes et al., 1992), and difficulty concentrating
(Gross, 1993; Sweet, 2010). Correlational and human self-report studies commonly suggest that
relapse to nicotine use is often brought about by these effects (Patterson et al., 2010). As posited
by Baker and colleagues (2004), smokers learn to detect physiological cues associated with the
early stages of nicotine withdrawal, which in turn prompt the rise of negative affect. As negative
affect intensifies, the incentive salience of drug-related cues increases, as does the probability
that an individual will partake in drug-taking behavior. Therefore, use of nicotine negatively
reinforces drug-taking behavior by attenuating the symptoms of negative affect, resulting in drug
dependence.
Given that urges and cravings may be theorized as subjective, motivational states
responsible for ongoing drug use and the inception of relapse, it is of value to attempt to
discriminate the relevant motivational factors that induce nicotine cravings and drive drug-taking
behavior. Carver and White’s (1994) Behavioral Inhibition and Inactivation Scales (BIS/BAS),
based on Gray’s (1987) biopsychological theory of emotion, have become widely used measures
of incentive processes, and can be used to better understand the motivational factors that underlie
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nicotine use. The aversive motivational system, called the behavioral inhibition system (BIS), is
hypothesized to control the experience of anxiety and to inhibit behavior that might produce
negative or painful outcomes. The BIS, according to Gray, is sensitive to cues of punishment,
non-reward, and novelty, and BIS functioning is responsible for negative affects like fear,
anxiety, frustration, and sadness in response to these cues (Carver & White, 1994). Therefore,
sensitivity to the BIS would reflect an individual’s propensity toward anxiety when provided
with the appropriate cues, and heightened avoidance of such anxiety-inducing experiences. On
the other hand, the psychologically independent behavioral activation system (BAS) is believed
to induce positive affects like elation and happiness in response to cues of reward, and thus
motivates goal-driven behavior toward cues.
The BIS scale is consistently defined as unidimensional in that it is said to singularly
regulate aversive motives in which the goal is to move away from something unpleasant (i.e. “I
feel worried when I think I have done poorly at something”), while the BAS scale can be broken
down into three distinct subscales: Drive, Reward Responsiveness, and Fun Seeking. In
examining the items that comprise these scales, the Drive scale exclusively assesses behavioral
responding (i.e. “If I see a chance to get something I want, I move on it right away”), Reward
Responsiveness exclusively evaluates affective responding (i.e. “When I get something I want, I
feel excited and energized”), and the Fun Seeking scale measures both affective and behavioral
responding (i.e. “I crave excitement and new sensations” and “I will often do things for no other
reason than that they might be fun;” Carver and White, 1994).
It has been suggested that the BAS is the basis for impulsivity, which in turn provides an
inclination toward risky behaviors like drug-seeking and drug use (Dawe & Loxton, 2004).
Zuckerman and Kuhlman (2000) argued that sensation seeking and impulsivity represent the
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approach aspect of the reward/risk conflict. Another way to account for the observed association
between impulsivity and risky behavior is in terms of disinhibition (Carlson et al., 2010), where
risk-taking occurs due to a weak BIS system. Given that impulsivity is related to greater risk of
substance use (Ham & Hope, 2003), Franken and Muris (2006) used the BIS/BAS questionnaire
to examine the influence of impulsivity on drug and alcohol use in college students. Their results
indicated that students’ drug and alcohol use was positively correlated with BAS personality
characteristics, and to a lesser extent, negatively correlated with BIS personality characteristics.
The most substantial correlations were found between the BAS Fun Seeking and BAS Drive
subscales and the number of illegal substances one had used, the quantity of alcohol use, and the
frequency of binge drinking. Therefore, they conclude that impulsivity, as determined by
BIS/BAS personality characteristics, significantly contributes to substance abuse.
Similar to the Behavioral Inhibition and Inactivation Scales, the Questionnaire on
Smoking Urges (QSU) is a metric that can be used to evaluate the multi-dimensional nature of
drug use, specifically in examining the motivational factors that drive urges and cravings. The
QSU uses a two-factor item structure characterizing (1) a desire and intention to smoke with
smoking anticipated as pleasurable (i.e. “I have an urge for a cigarette” and “I have no desire for
a cigarette right now”), and (2) an anticipation of relief from negative affect and nicotine
withdrawal with an urgent desire to smoke (i.e. “‘All I want right now is a cigarette” and “My
desire to smoke seems overpowering;” Tiffany & Drobes, 1991). The QSU has been shown to
display high internal consistency across settings with smokers at differing stages of drug use,
providing convenient and reliable assessment of desire to smoke (Cox et al., 2001); thus, in using
this questionnaire, one may be able to discriminate the relevant motivational factors that induce
nicotine cravings and drive drug-taking behavior. In an effort to correlate the relationship
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between nicotine dependence and “background craving,” defined as the craving that smokers
experience irrespective of nicotine-associated cues (Ferguson & Shiffman, 2009), one study
found that more dependent smokers reported higher background craving on both appetitive and
distress relief factors of the QSU prior to any cue exposure (Dunbar et al., 2014).
As mentioned, impulsivity is an additional factor involved in the initiation of drug use.
Impulsivity describes an individual’s propensity to make rash behavioral decisions regardless of
adverse consequences, or the loss of a delayed reward of greater magnitude (i.e. drug taking
despite knowing the potential detrimental effects on health). Studies in laboratory animals can
measure degrees of impulsivity by evaluating whether rodents preferentially lever press to
receive smaller, immediately-available food rewards, or larger, delayed food rewards (Dierrgarde
et al., 2008). Consistent with this measurement of delayed discounting, human dependence on
nicotine has been found to be associated with high levels of impulsivity (Kolokotroni et al.,
2011; Ryan et al., 2013) where nicotine users tend to opt for the smaller, more immediate
reward, while rating the larger, delayed reward as having a relatively lower subjective value
(MacKillop et al., 2011; Yi et al., 2010). The Monetary Choice Questionnaire (Kirby, 1996) is
often used is human studies to measure individual differences in delayed discounting, which
involves choosing between immediate, but smaller theoretical monetary rewards and delayed,
but larger rewards. Recently, Konecky and Lawyer (2015) indicated that substance-abusing and
substance-dependent adolescents evidenced significantly higher rates of delay discounting than
did non-drug-abusing controls in that those who met criteria for substance abuse or dependence
were more likely to choose a smaller-sooner reward over a larger-later reward than were nonabusing controls. Their findings were consistent with others linking higher rates of delay
discounting with adolescent (Reynolds & Fields, 2012) and adult substance abuse (MacKillop et
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al., 2011). Due to the significance of impulsivity on decisions of delayed discounting and
increased rates of substance abuse, it is of relevance to assess the relationship between responses
on the Kirby questionnaire and nicotine cravings and drug-taking behavior.

Reward learning in nicotine dependence
A multitude of diverse studies including self-administration, electrical self-stimulation,
place preference, pharmacology, in vivo imaging, and cellular electrophysiology have suggested
that the neurotransmitter, dopamine (DA), plays a critical role in both instrumental and classical
conditioning(Dani, 2003). In classical conditioning, any change in behavior reflects an innate
reaction to environmental events. Conversely, in instrumental conditioning, behavior is
dependent on whether or not an animal gets a reward or punishment.
As mentioned, nicotine dependence in part stems from the expectation that nicotine use
will produce positive emotional consequences, or relieve negative affect from stress and
withdrawal. Therefore, an assertion that has guided much research is that the reinforcement
mediated by psychostimulant drugs like nicotine is associated with enhanced DA release from
the mesocorticolimbic system that originates in the ventral tegmental area (VTA) and innervates
the amygdala, nucleus accumbens, prefrontal cortex, and striatum via dopaminergic
projections(Di Chiara, 1988; Balfour, 2004). Nicotine has been shown to directly increase DA
levels in the mesocorticolimbic system by interacting with nicotinic acetylcholine receptors
(nAChRs) on dopaminergic neurons causing them to release more of the DA neurotransmitter
(Koob & Valkow, 2010). These findings suggest that nicotine use taps into reward-based
neuronal systems, reinforcing maladaptive behaviors. The primary reinforcing effects of nicotine
use have been demonstrated by an increase in self-administration behavior in both human and

7

non-human studies to nicotine administration. For example, it has been shown that animals are
significantly more likely to lever press when the press results in a nicotine infusion than when it
results in placebo (LeFoll & Goldberg, 2009). Similarly, Henningfield and colleagues (1983)
demonstrated that human cigarette smokers show increased patterns of responding for
intravenous nicotine versus saline in a self-administration paradigm.
However, nicotine users do not simply self-administer nicotine, but they take the drug
within the context of numerous external stimuli. These neutral stimuli can be either intrinsic or
extrinsic to nicotine itself, and include things like the sight, smell, and taste of a cigarette, or the
context where nicotine's actions take place. Nicotine-associated stimuli then promote nicotineseeking behavior and use (DiChiara, 2000). The association between such cues and the resulting
urge to use nicotine constitutes classical conditioning, in which dopamine is also implicated.
Classical/Pavlovian conditioning occurs when a neutral stimulus, for example, a drugrelated cue, is repeatedly paired with a stimulus that evokes some type of innate response, termed
an unconditioned stimulus (US). Self-administered drugs are considered effective unconditioned
stimuli since they have been shown to possess powerful physiological and hedonic properties.
Following consistent and repeated pairings of the neutral drug-related cue with the US, the cue
may come to act as a conditioned stimulus (CS), triggering the same response as that produced
by the US. The desire to use nicotine is partly maintained by such conditioning (Stewart et al.,
1984). For example, smokers tend to have a cigarette after a meal or with friends who smoke.
When these situations are repeated, they become cues for the urge to smoke. Demonstrating this
phenomenon, several studies have shown that when smokers were exposed to smoking cues, like
a lit cigarette resting in an ashtray, they reported increased cravings or “desire to smoke” (Wertz
& Sayette, 2001; Sayette & Tiffany, 2013).
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While the primary reinforcing effects of nicotine and the subsequent associative and
classically-conditioned properties of nicotine-related stimuli are important in instigating nicotine
cravings and drug use, recent studies suggest that non-associative effects of nicotine on
reinforced behavior may also play an important role in that behavior changes in the absence of
any apparent nicotine-associated stimulus or event (Caggiula et al., 2009). Studies utilizing
animal models suggest that nicotine can promote the reinforcing properties of nonpharmacological rewards that are not directly associated with nicotine intake. In other words,
nicotine may increase the incentive value of a non-nicotine stimulus by directly enhancing the
reinforcing efficacy of other reinforcing stimuli in the environment.
In a study originally conducted by Donny et al. (2003), nicotine increased responding for
a reinforcing, concurrently-available visual stimulus. Particularly, the increase in responding did
not occur with non-contingent food delivery, and was regulated by nicotine delivery as
demonstrated by an immediate reduction in responding when nicotine was replaced with saline
(Chaudhri et al., 2007). Importantly, operant responding for the visual stimulus was sustained at
high levels by nicotine that was neither temporally nor causally associated with behavior,
suggesting that this effect was distinct from the actions of nicotine as a primary reinforcer
(Rupprecht et al., 2015). Rodent studies by Guy and Fletcher (2013) also substantiate the
hypothesis that nicotine increases appetitive responding for non-drug incentives by
demonstrating that nicotine administered during conditioning promoted operant responding for
the delivery of water. Furthermore, enhanced responding for water delivery induced by nicotine
was blocked by mecamylamine and DHβ, nicotinic antagonists.
Findings of reinforcement enhancement by nicotine in non-humans have been replicated
across a range of doses, routes of administration, schedules of reinforcement, and reinforcing
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stimuli, including conditioned reinforcers (Chaudhri et al., 2006; Palmatier et al., 2006).
However, literature regarding nicotine’s ability to promote non-associative reinforcement in
humans has received less attention. Of the few existing studies, observations are consistent with
non-human literature. A study by Attwood et al. (2009) sought to determine the impact of
nicotine on hedonic behaviors using ratings of facial attractiveness. Participants in withdrawal
were randomized to smoke either a nicotine-containing or a denicotinized cigarette after which
they completed ratings of attractiveness of male and female faces. Their data indicated that while
nicotine treatment increased ratings of attractiveness, it did not significantly affect ratings of
subjective mood, suggesting that the effects on attractiveness ratings were distinct and not
reflective of a positivity bias in questionnaire responding for the nicotine condition.
Similarly, using a signal detection task designed to measure shift in responding toward a
differentially (more) rewarded stimulus, Barr et al. (2008) concluded that transdermal nicotine
increased response bias towards the more rewarded stimulus compared to placebo. Specifically,
non-dependent and nicotine-naïve participants were asked to choose which of two stimuli (a
short or long mouth) was displayed on a previously mouthless cartoon face. Correct
identification of one stimulus was rewarded (“Correct!! You won 5 cents”) three times more
frequently compared with correct identification of the other stimulus. While participants were
told that not all correct responses would receive a reward feedback, that lack of feedback did not
indicate inaccuracy, and that they receive no feedback for errors, they were not informed about
the differential reward schedule. Despite anticipated adverse effects like nausea, nicotine
significantly increased response bias toward the more frequently rewarded condition at the
expense of accuracy, and independent of effects on attention or overall vigilance (Barr et al.,
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2008) supporting the hypothesis that nicotine increases the reinforcing salience of a non-nicotine
stimulus.
Finally, in an attempt to determine the generalizability of nicotine’s ability to enhance
reinforcement, one study assessed the effects of nicotine via smoking on enhancement of positive
reinforcers like money or music, or negative reinforcers like the termination of an aversive noise
(Perkins & Karelitz, 2013). Using a within subjects design, dependent and non-dependent
smokers participated in several sessions involving an “Applepicker” computer task (Norman &
Jongerius, 1985) in which participants were required to search for apples on virtual trees.
Participants received visual feedback when an apple was found, signaling that a unit of reward
selected for that trial had been earned. Each 15-minute trial per session differed in the type of
reward that was available as a reinforcer. Upon earning a reinforcer, subjects could continue
responding on the task to earn additional units of the reinforcer, or they were free to stop
responding at any point and could simply wait quietly, or read provided magazines until the end
of the 15-min task period. Virtually all participants stopped responding at some point before the
end of the trial indicating that maximal responding for a reinforcer was reached. Prior to each
session, participants who abstained from smoking overnight smoked either a nicotine-containing
or denicotinized cigarette, or smoked nothing at all.
Similar to previous findings, the results of the study determined that reinforced responses
were significantly greater following smoking of nicotine cigarettes, compared to smoking
denicotinized cigarettes or no smoking. Furthermore, these reinforcement enhancing effects of
nicotine via smoking did not differ between dependent and nondependent smokers (Perkins &
Karelitz, 2013). Notably, nicotine only enhanced responding for music reinforcers, but not
monetary reinforcers or the negatively reinforcing termination of aversive noise, suggesting that
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additional human research is necessary in better understanding the specificity of nicotine's
reinforcement enhancement.

The conditioned place preference paradigm
In non-human studies, the reward properties of drugs are frequently assessed using an
experimental design called conditioned place preference (CPP), which measures the extent to
which a rodent chooses to be in an environment that has been repeatedly paired with the
appetitive effects of a stimulus. Drugs of abuse induce preference for the environment that has
been repeatedly paired to its effects, resulting in what is termed a “conditioned place preference”
(Carr et al., 1989). Generally, the task involves two contextually distinct compartments joined by
a connecting tunnel. The two compartments may differ across modalities such as visual,
auditory, tactile and olfactory cues. During the task, the animal is confined to one of the two
compartments for a fixed amount of time, and is given a rewarding substance, like food or drug.
Later, in a separate session, the animal is confined to the other compartment and receives a
placebo for an equal amount of time. These pairings are repeated to strengthen the association
between context and presence or absence of the reward. Following the pairing sessions, a test
session is given in which the animal receives unrestricted access to both compartments without
any reward or placebo. Typically, animals demonstrate a strong preference for the room in which
the reward was previously paired despite the reward no longer being present (van der Kooy et al.,
1987). Pavlovian conditioning is the most widely accepted explanation for the CPP since it is
believed that the context paired with the reward becomes a conditioned stimulus that predicts the
presence of the reward.
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Advantages to CPP have been documented in a thorough review by Carr et al. (1989),
indicating that the task is sensitive to low drug doses, can be obtained in a single drug-pairing
(Bardo, 1999), does not require a surgical procedure, and measures the effects of both reward
and aversion. Furthermore, the test measurements are made in the absence of the drug; therefore,
drug effects like motor impairment or sedation do not confound the results. CPP can be elicited
by a number of natural rewards such as food, water, copulatory opportunity, and opportunity for
social interaction (Tzschentke, 1998), as well as by a variety of drugs (Mattson et al., 2003).
Nicotine has been shown to produce CPP over a wide range of doses after both peripheral
(Fudala et al., 1985; LeFoll & Goldberg, 2004) and central administration (Iwamoto, 1990). One
study reported that effects of nicotine CPP persisted for 3 and 12 weeks without further
conditioning (Forget, Hamon & Thiebot, 2005). Furthermore, mecamylamine, a nicotine
antagonist, has been found to block the effects of nicotine (Fudala et al., 1985), and thus block
nicotine-induced CPP.
Another advantage of CPP is that it is adaptable to a variety of laboratory animals
(Hughes et al., 1995; Foltin & Evans, 1997), and recently has been translated to human studies
(Childs & de Wit, 2009). Our lab has previously demonstrated that food-deprived undergraduates
display a significant CPP for a virtual reality room previously-paired with a chocolate reward
(Astur et al., 2014). To extend the standard CPP paradigm to humans, we created a virtual reality
(VR) conditioned place preference task. The virtual environment consisted of two visually
distinct virtual rooms connected by a neutral hallway. Using a two-day procedure, food-deprived
undergraduates completed six, 6-minute conditioning sessions on the first day, navigating the
environment with a joystick. One room was paired with real-life M&Ms for three sessions where
participants were instructed to eat the M&Ms as they were dispensed, while the opposite room

13

was paired with no food for three sessions. The room that was paired with M&Ms and the orders
of the pairing sessions were counterbalanced. Twenty-four hours following the conditioning
sessions, participants returned for a test session where they were placed in the same virtual
environment, but started in the neutral hallway. They had access to both rooms for the entire 6minute session; however, no M&Ms were dispensed throughout the test session. Our results
indicate that participants displayed a significant CPP as evidenced by amount of time spent in the
previously-M&M paired room. Furthermore, using subjective self-report measures similar to
those implemented by Childs and de Wit (2009), we observed that participants explicitly
indicated that they preferred the food-paired room, and showed a trend for rating that room more
favorably. Hence, both implicit and explicit measures indicated a CPP to chocolate in humans
(Astur, 2014). Given the success of the CPP task in assessing basic reward mechanisms in nonhumans, we were interested in examining whether this task could lend insight into the
mechanisms underlying the known enhancement of reward-sensitivity by nicotine.

Chapter Two: Present Experiment
Introduction to the current study
The present study sought to examine nicotine’s ability to increase the sensitivity of
reward properties by enhancing responding for non-drug incentives in humans using a virtual
CPP task. Not only is there a lack of information concerning nicotine’s role in human
reinforcement enhancement, but even fewer studies have been conducted utilizing the hallmark
conditioned place preference paradigm to analyze the multi-faceted effects of nicotine on reward.
Therefore, using a novel virtual reality translation of the CPP task, one goal of the present study
is to investigate whether nicotine will enhance CPP for a chocolate food reward.
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In addition to enhancing the reinforcing properties of non-nicotine stimuli, nicotine has
also been shown to delay the rate of extinction for previous conditioning in that animals continue
to respond for previously-rewarded stimuli that are no longer reinforced. One study
demonstrated that nicotine infusions increased operant responding for alcohol, and that
extinction of responding for alcohol was delayed by the infusion of nicotine (Clark et al., 2001).
In examining the effects of nicotine administration on the extinction of conditioned fear
memories, Elias et al. (2010) found that nicotine enhanced extinction when administered only
prior to extinction sessions. However, when nicotine was administered before both the
acquisition of the conditioned fear response and before extinction, the rate of extinction was
delayed. These findings indicate that while nicotine may facilitate extinction, when it is
administered at both training and extinction, nicotine strengthens contextual associations formed
during training, and these enhanced contextual associations can interfere with extinction when
extinction occurs in the same context as used for training (Elias et al., 2010) suggesting a
somewhat complicated role for nicotine in the extinction process.
Extinction for CPP occurs when non-rewarded exposure to environmental contexts
previously paired with rewarding stimuli reduces subsequent CPP. Brenhouse and Andersen
(2008) found that rats formed reliable place preferences for cocaine, and that adolescent rats
required significantly more extinction sessions than adults to extinguish cocaine CPP. However,
to date, no studies have been conducted examining the effects of nicotine on extinction using
place conditioning. Therefore, the present study aims to determine whether nicotine slows the
rate of extinction in humans for a virtual room paired with a chocolate food reward.
Finally, nicotine has been shown to increase vulnerability to reward-primed reinstatement
after extinction where non-contingent administration of the reward is administered in a neutral
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context and reinstates behavior after periods of non-responding (de Wit & Stewart, 1981). In
other words, animals are more sensitive to the recovery of former conditioning if they have
previously received nicotine. In studying the effect of nicotine on alcohol self-administration and
reinstatement after extinction, Le and colleagues (2003) found that nicotine significantly
reinstated alcohol seeking after extinction of the alcohol-reinforced behavior, leading to intake
levels that were more than twice of those of the saline-treated group. Furthermore, this effect was
strongly enhanced by prior nicotine exposure. In the previously-mentioned study by Brenhouse
& Andersen (2008), not only did cocaine delay adolescent rats’ ability to extinguish learned
place preferences for cocaine-paired environments, but it was found that adolescents were also
more vulnerable to drug-primed reinstatement of CPP after extinction, displaying significant
reinstatement for a lower conditioning dose of cocaine than adults, and spending more time than
adults in a previously drug-paired environment. Again, however, there exists an absence of
literature examining nicotine’s effects on reinstatement using the CPP task. Therefore, the
present study aims to determine whether nicotine will promote the reinstatement of an
extinguished CPP.
Combined, these studies indicate that it is of value to understand the behavioral,
emotional, and neuropharmacological mechanisms by which nicotine enhances responding for
conditioned rewards. Accordingly, the aim of the present study was to (1) assess whether
nicotine increases the sensitivity of reward properties by enhancing the strength of food-reward
conditioning, (2) determine whether nicotine delays extinction when exposure to a virtual room
previously-paired with food is no longer rewarded, and (3) determine whether nicotine increases
the possibility of reinstatement of previous conditioning. We hypothesize that participants who
receive nicotine prior to conditioning will demonstrate a stronger conditioned place preference in
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our virtual paradigm in terms of the amount of time spent in and the subjective ratings of the
previously-rewarding room. Additionally, we hypothesize that nicotine administration will
significantly delay the rate of extinction of the CPP, as demonstrated by continued preference for
the previously-rewarding room despite it no longer being paired with a reward. And finally, we
hypothesize that nicotine will increase the strength of reinstatement of the CPP, such that
participants will spend significantly more time in the food-paired room relative to the extinction
sessions.

Materials and Method
Participants
Ninety-six University of Connecticut undergraduates (avg. age = 19.5 yrs; SD = 1.18; 25
females) were recruited from introductory psychology classes. Of these participants, Day 1 data
from 30 participants was discarded, and Day 2 data from 24 participants was discarded due to
ineligibility (i.e. ate before experiment, used nicotine before experiment as monitored by CO
detector, felt nauseated during experiment, incorrect lozenge administration, did not enjoy
chocolate). This resulted in usable Day 1 data from 72 participants (avg. age = 19.3 yrs; SD =
1.12; 16 females), and usable Day 2 data from 62 participants (avg. age = 19.3 yrs; SD = 1.19; 16
females; Day 1/Day 2: Nicotine/Nicotine, n = 20; Nicotine/Placebo, n = 38; Placebo/Nicotine, n
= 22; Placebo/Placebo, n = 32). On average, 10.6 (SD = 8.9) nicotine-containing products were
used weekly. Participants were required to abstain from eating and from using nicotine for six
hours prior to the experiment. In order to participate, participants were required to have no preexisting cardiac conditions, and female participants could not be pregnant. It was also required
that participants were willing to eat chocolate for the purposes of this experiment. Participants
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received class credit for their participation. Approval for this study was obtained from the
University of Connecticut Institutional Review Board.

Apparatus
An IBM-compatible computer with a SVGA color monitor was used for testing.
Participants seated at the computer navigated through the virtual environments by manipulating a
joystick. A speaker connected to the computer was used to provide auditory feedback and a Med
Associates Inc. ENV-203IR pellet dispenser was used to dispense M&Ms into a tray for the
participant to consume.

Procedure
This was a two day study with each daily session lasting approximately one hour. On Day
1, food-deprived participants arrived in the morning between 8:30 and 10:30AM, and consent
was obtained. All participants were required to blow into a CoVita Smokerlyzer carbon
monoxide sensor, which was used to determine whether they had smoked within the last 6 hours.
Anyone that had smoked within the last 6 hours (PPM <10; Perkins et al., 2012) was asked to
reschedule their appointment. If the participant was female, she was asked to take a urinalysis
pregnancy test that must be negative. Participants were then asked to complete a brief
demographics questionnaire consisting of questions regarding age, sex, when the participant last
ate, when the participant last used nicotine, and items like level of hunger on a 1-10 scale (1
being “not at all”).
Following completion of the demographics questionnaire, participants were randomly
selected to receive either a 4mg nicotine lozenge or a similar-tasting placebo. The 4mg lozenge
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was chosen for nicotine treatment because studies investigating nicotine absorption from several
nicotine replacement products have found that, of the smokeless products, the 4mg nicotine
lozenge resulted in the greatest blood nicotine levels across a 1-hour timeline, with levels
peaking 15-minutes after administration (McEwan et al., 2008). Participants were instructed to
place the lozenge in their mouth, occasionally moving it from side to side to allow it to slowly
dissolve over the course of 15 minutes. They were told to minimize swallowing, and not to chew
or swallow the lozenge.
While the lozenge or placebo dissolved, participants completed several additional
questionnaires administered in the order described. The Fagerstrom Test for Nicotine
Dependence (Fagerstrom, 1989) is a standard instrument for assessing the intensity of physical
dependence to nicotine. It contains six items that evaluate the quantity of cigarette consumption,
the compulsion to use, and dependence. Given that cravings are one of the most prominent
symptoms of nicotine dependence and are a significant predictor of nicotine relapse, we also use
the Questionnaire on Smoking Urges (Tiffany & Drobes, 1991), a 10-item self-report measure.
The Behavioral Inhibition and Activation Scale (BIS/BAS; Carver & White, 1994) is another
questionnaire used that aims to assess the differences in the two motivational systems that likely
contribute to cravings and relapse. Finally, the Kirby Monetary Choice Questionnaire (Kirby &
Marakovic, 1996) is used to measure a person’s level of impulsivity in terms of delay
discounting– or whether or not an individual can delay reward choices.
After completing the surveys, and 15-minutes after administration of the lozenge or
placebo to maximize absorption (McEwan et al., 2008), participants were guided through a brief
tutorial on how to interact with the virtual environment using a joystick in a 90-second practice
session where they were placed in a barren virtual reality (VR) room. To encourage exploration

19

in both the practice and experimental sessions, a downward facing arrow appeared periodically
in random locations and participants were required to locate and collide with the arrow. Three to
five M&Ms were dispensed during the practice session, and participants were instructed that
throughout the experiment they are to eat the M&Ms as they were dispensed. Participants were
allowed to ask questions at any time.
After completing the practice session, each participant completed six, three-minute
experimental pairing sessions in a virtual environment. A short, 1-minute break followed each
session. The environment consisted of two visually-distinct rooms connected by a neutral
hallway (see Fig. 1A). In each of the six experimental sessions, the participants were confined to
one of the two rooms and were to explore the environment using the joystick. One room was
paired with real M&Ms for three sessions, while the opposing room was paired with no food for
three sessions. The room paired with M&Ms and the orders of the pairing sessions were
counterbalanced. One M&M was dispensed periodically into a cup next to the participant during
the M&M sessions, and the participant was instructed to eat the M&Ms as they were dispensed.
Specifically, an M&M was dispensed every 21s + 5 s. Between 25-30 M&Ms total were
dispensed over the course of the experiment, which is approximately half the amount in a regular
47.9g single size bag of M&Ms. After all six pairing sessions were completed, a 10-minute break
was given before the test session (see Fig. 1B for a sample testing sequence).
For the test session, participants were placed in the same virtual environment and started
in the neutral hallway. They had access to both rooms for the entire three-minute session via a
door between the two rooms, but were locked out of the neutral hallway once they first entered a
room. M&Ms were not dispensed during the test session. After the test, participants were given a
survey. Questions asked which of the two rooms they preferred, how much they enjoyed each
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room on a scale of 0-100 (0 being “not at all”), and how much they enjoy chocolate on a scale of
0-100 (0 being “not at all”).
On Day 2, participants were again asked to complete the carbon monoxide test.
Participants were then randomly selected to either receive a 4mg nicotine lozenge or the similartasting placebo. To test for extinction, the participant underwent three, 3-minute test sessions, as
described on Day 1, in which they had unrestricted access to both VR rooms where no M&Ms
were given. One-minute breaks were given between each session. After the test sessions,
participants underwent a 60-second reinstatement session in which they received M&Ms in a
neutral, novel VR room. After a 10-minute break, participants once more underwent a test
session to test for possible reinstatement (see Fig. 1B for a sample testing sequence). After the
test, participants were given a survey asking which of the two rooms they preferred, how much
they enjoyed each room on a scale of 0-100 (0 being “not at all”), and how much they enjoy
chocolate on a scale of 0-100 (0 being “not at all”). Finally, at several points throughout the
experiment on both Day 1 and 2, participants were asked questions about their subjective mood
on a visual analog scale (VAS). VAS questions inquired how buzzed the participant felt, how
nauseated, how dizzy, how hungry, how anxious, and how much they craved nicotine and/or
chocolate.

Results
In examining participants’ levels of nicotine dependence, we found that most users in our
sample demonstrated low levels of dependence with an average Fagerstrom score of 1 (SD =
1.43). While we did not collect information categorizing methods of consumption (i.e. ecigarettes, cigarettes, snuff, etc.), participants did report using an average of 10.6 (SD = 8.9)
nicotine-containing products weekly. Conditioned place preference scores were calculated as
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difference scores by subtracting the amount of time spent in the non M&M-paired room from the
amount of time spent in the M&M-paired room during the test session, such that any score
greater than zero indicated a conditioned place preference for the M&M-paired room. Difference
scores in ratings were also calculated this way.
In support of previous findings by our lab (Astur et al., 2014), placebo-treated
participants demonstrated a significant CPP by spending significantly more time in the
previously-paired M&M room on test day (t(38) = 1.99, p = 0.04; Figure 2A). Nicotine-treated
participants, however, did not display a significant CPP in terms of time (t(33) = 0.67, p = 0.51;
Figure 2A). Additionally, there were no significant differences in time between treatment groups
(F(1,72) = 0.25, p = 0.62; Figure 2B). When examining subjective ratings as a measure of CPP,
neither the nicotine group (t(33) = 0.68, p = 0.50) nor the placebo group (t(38) = -0.41, p = 0.69)
demonstrated a significant CPP; in other words, there was no difference in ratings of how
enjoyable the M&M-paired room was compared to the no M&M room after testing. Moreover,
there were no significant ratings differences between treatment groups after testing (F(1,72) =
0.64, p = 0.43; Figure 2B).
In an attempt to determine whether individuals with greater nicotine dependence
condition differently than those with lesser or no dependence, we specifically examined the 36
participants who scored greater than zero on the Fagerstrom questionnaire, a metric that assesses
levels of nicotine dependence where a zero score indicates no dependence, a 1-5 score indicates
low to moderate dependence, and anything greater than 5 indicates high dependence. For
individuals with a Fagerstrom score greater than 0, the M&M-paired room was rated as
significantly more enjoyable for the nicotine group compared to the placebo group (F(1, 35) =
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4.72, p = 0.04; Figure 3). However, there were no significant differences between treatment
groups in terms of time (F(1, 35) = 0.25, p = 0.62).
Given that urges and cravings have been shown to be responsible for ongoing drug use
and the inception of relapse, we next attempted to discriminate whether an individual’s
subjective, motivational states affected CPP. In examining whether total BIS/BAS scores
differentially affected CPP for the nicotine or placebo groups, we found no significant effects on
time or ratings (Table 1).
Table
1.

Nicotine

Placebo

CPP Time

CPP Ratings

CPP Time

CPP Ratings

BIS

F(1, 33) = 0.21,
p = 0.95

F(1, 33) = 0.67
p = 0.78

F(1, 38) = 0.65,
p = 0.74

F(1, 38) = 0.24,
p = 0.98

BAS

F(1, 33) = 0.40,
p = 0.87

F(1, 33) = 2.76,
p = 0.45

F(1, 38) = 0.45,
p = 0.90

F(1, 38) = 0.27,
p = 0.98

Specifically analyzing the individual BAS Subscales (Drive, Reward Responsiveness
(RR), and Fun Seeking (FS)), we found that the nicotine group scored significantly higher on the
BAS Drive subscale than did the placebo group (F(1, 72) = 5.47, p = 0.02). To examine this
further, we performed median splits on all subscales to divide participants into groups of high
and low responders. We found no significant time or ratings differences between treatment
groups on any of the BAS subscales, regardless of high or low scores (Table 2). Furthermore,
there were no significant differences between treatments in time or ratings regardless of whether
participants scored in the upper or lower 50% on the BIS (Table 2).
Time
Table 2.

BAS Drive
BAS RR

High
Responders
(upper 50%)
F(1, 37) = 0.003,
p = 0.96
F(1, 38) = 0.54,

Low
Responders
(lower 50%)
F(1, 34) = 0.41,
p = 0.53
F(1, 19) = 2.58,

Ratings
High
Responders
(upper 50%)
F(1, 37) = 2.49,
p = 0.12
F(1, 38) = 0.66,

Low
Responders
(lower 50%)
F(1, 34) = 0.57,
p = 0.45
F(1, 19) = 0.90,
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BAS FS
BIS

p = 0.47
F(1, 28) = 0.13,
p = 0.72
F(1, 35) = 0.001,
p = 0.97

p = 0.13
F(1, 43) = 0.18,
p = 0.68
F(1, 36) = 0.14,
p = 0.71

p = 0.42
F(1, 28) = 0.84,
p = 0.37
F(1, 35) = 0.89,
p = 0.35

p = 0.36
F(1, 43) = 0.002,
p = 0.98
F(1, 36) = 0.004,
p = 0.95

Using a second measure to understand the association between underlying motivation to
smoke and CPP, we assessed the relationship between CPP and scores on the Questionnaire on
Smoking Urges and its two subscales: Urge to Smoke and Relief of Negative Affect. We found
no significant correlations between time or ratings CPP and total QSU, Urge to Smoke, or Relief
of Negative Affect scales (Table 3).
Table 3.
Total QSU
Urge to Smoke
Relief of Negative Affect

Time
r(73) = 0.19, p = 0.87
r(56) = 0.12, p = 0.39
r(56) = 0.07, p = 0.61

Ratings
r(73) = 0.07, p = 0.56
r(56) = 0.01, p = 0.92
r(56) = 0.07, p = 0.61

However, performing a median split on the QSU subscales, we found that nicotinetreated participants who scored in the upper 50% on the Urge to Smoke subscale, demonstrating
a strong desire and intention to smoke with smoking perceived as rewarding, rated the M&Mpaired room as significantly more enjoyable compared to placebo-treated participants (F(1,36) =
3.19, p = 0.04). There was no significant difference in CPP between treatments in terms of time
(F(1, 36) = 0.27, p = 0.34) using the Urge to Smoke subscale. Furthermore, regardless of
whether individuals scored in the upper or lower 50% on the Relief of Negative Affect scale,
there were no significant differences in treatments in terms of time or ratings (Table 4).
Time
Table 4.
Relief of
Negative Affect

High
Responders
(upper 50%)
F(1, 30) = 0.21,
p = 0.65

Lower
Responders
(lower 50%)
F(1, 34) = 0.00,
p = 0.99

Ratings
High
Responders
(upper 50%)
F(1, 30) = 0.16,
p = 0.69

Lower
Responders
(lower 50%)
F(1, 34) = 0.08,
p = 0.78
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Recognizing that an additional factor involved in the initiation of drug use is impulsivity,
further Day 1 analyses found a no significant correlations between the Kirby Monetary Choice
Questionnaire (Kirby) and treatment differences in ratings (r(73) = -0.30, p = 0.79), or time
(r(73) = 0.20, p = 0.10). However, performing a median split on scores of the Kirby revealed a
significant difference between treatment groups in terms of time spent in the M&M-paired room
for participants who scored in the upper 50% on the Kirby Monetary Choice Questionnaire
(F(1,33) = 3.17, p = 0.02). In other words, participants in the nicotine-treated condition who
score as more impulsive on the Kirby questionnaire were more likely to show a CPP.
We next aimed to characterize the effects of nicotine on extinction and reinstatement.
When examining extinction, it is worthwhile to analyze those who acquired a CPP on Day 1
since those who did not display a CPP may not have acquired the necessary learned associations
needed to readily show extinction. Looking at Day 2 drug effects in nicotine-dependent
participants who demonstrated a CPP on Day 1 (Fagerstrom > 0; CPP Difference Score > 0),
there was no significant time CPP for the nicotine group or placebo group in extinction sessions
1 or 2 (Table 5). Furthermore, no significant differences in time were seen between Day 2
treatments for the first (F(1, 18) = 0.02, p = 0.90) or second (F(1, 18) = 1.80, p = 0.20) extinction
sessions. However, we did find that those who received placebo on Day 2 showed a CPP during
the third extinction session by spending significantly more time in the M&M-paired room than
Day 2 nicotine-treated participants (F(1, 18) = 5.01, p = 0.04). What is more, individuals who
received nicotine on Day 1 spent significantly more time in the M&M-paired room during the
third extinction session than placebo-treated participants (F(1, 18) = 13.7, p = 0.002; Figure 4).
Therefore, nicotine administration on Day 1 and placebo administration on Day 2 appear to be
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the most influential in determining whether the participant will demonstrate a conditioned place
preference during the third extinction session (Figure 6).
Table 5.
Extinction Session 1 (E1)
Extinction Session 2 (E2)

Nicotine
t(16) = 0.62, p = 0.56
t(16) = -1.56, p = 0.14

Placebo
t(17) = 0.57, p = 0.58
t(17) = 0.42, p = 0.68

Finally, while there were no significant differences between Day 1 treatments in terms of
time during the reinstatement session (F (1, 18) = 3.39, p = 0.83), participants who received
nicotine on Day 2 reinstated by a significantly greater change between the amount of time spent
in the M&M-paired room during the last extinction session and the reinstatement session
compared to placebo-treated participants (F(1, 18) = 5.87, p = 0.03; Figure 8).

Chapter Three: General Discussion
The present experiments were undertaken to characterize the effects of nicotine on
conditioned responses in humans using a virtual CPP paradigm. More specifically, these studies
were conducted to (1) determine whether nicotine increases the sensitivity of reward properties
by enhancing the strength of food-reward conditioning, (2) assess whether nicotine delays
extinction when exposure to a virtual room previously-paired with food is no longer rewarded,
and (3) determine whether nicotine increases the possibility of reinstatement of previous
conditioning after extinction.
Overall, the present results demonstrated that nicotine does seem to enhance conditioning
for a food reward during the virtual CPP task as evidenced by participants who are dependent on
nicotine rating the M&M-paired room as significantly more enjoyable when they receive
nicotine on Day 1. Nicotine also seems to make individuals more resistant to extinction since
those who received nicotine on Day 1 revealed an increased preference for the M&M room in the
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last extinction session. Lastly, nicotine on Day 2 seems to promote reinstatement of the
conditioned behavior following a small amount of M&Ms given in a neutral context after
extinction.

Contributions of the current work to the literature
Day 1 of the present study demonstrated that by employing a novel virtual CPP task,
nicotine enhances the sensitivity of non-pharmacological rewards in humans that are not directly
associated with nicotine intake. For nicotine-treated participants who demonstrate some level of
nicotine dependence, the M&M-paired room was rated as significantly more enjoyable compared
to placebo-treated participants. This finding supports those of previous studies illustrating
nicotine’s ability to increase appetitive responding for non-drug incentives (Donny et al., 2003;
Chaudhri et al., 2007; Raiff & Dallery, 2008; Atwood et al., 2009; Guy & Fletcher; 2013;
Perkins & Karelitz, 2013). Understanding the relationship between nicotine dependence and
conditioning is important in that dependence indices have been shown to predict cue-induced
cravings and subsequent relapse. Sayette et al. (2003) reported that craving responses to cues are
greater in dependent versus non-dependent smokers. Following this research, Erblich (2004)
found that responses on a five-item self-reported craving scale to an in vivo cue (holding an unlit
cigarette), but not to an imagined cue (thinking about smoking in certain situations), were
associated with self-reported shorter duration of abstinence during a prior quit attempt.
Furthermore, it has been shown that measures of nicotine dependence predict differential
responses to smoking cessation treatments (Zelman et al., 1992). Therefore, differentiating
dependence severity and understand the role of dependence in conditioning is of practical
importance.
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Interestingly, while we were able to demonstrate a CPP in placebo-treated participants in
terms of the amount of time spent in the M&M-paired room, we were not able to produce a
reliable CPP in nicotine-treated participants. CPP procedures designed to assess drug preferences
in non-humans rely on certain implicit assumptions regarding the positive effects of drugs.
Particularly, it is assumed that drugs produce similar subjective states in non-humans as they do
in humans. Thus, when an animal spends more time in the previously reward-paired
compartment of the place preference chamber, it is inferred that the environment has acquired
rewarding properties through association with pleasurable drug effects. By examining subjective
ratings of a reward-associated environment, it is assumed that there would be a logical
relationship between measures of room preference and the incentive effects of the reward, such
that more positive (elation and positive mood) and less negative (anxiety and dysphoria)
subjective effects would predict liking of the rewarding room. Given that nicotine-treated
subjects revealed significantly higher subjective ratings of the food-paired room, we infer that
nicotine enhanced reward-sensitivity of the M&M room. Similar results of an explicit place
preference, in terms of subjective ratings, in the absence of an implicit place preference, in terms
of time, have been documented by others when examining drug effects on humans (Childs & de
Wit, 2009; Childs & de Wit, 2011). Therefore, nicotine’s influence on subjective responses to
food-rewards contribute to its ability to establish place conditioning, but the relationship between
quantitative ratings of liking of a room and whether this sufficiently corresponds to the
behavioral measure obtained in animals in terms of time spent in one or the other remains to be
investigated.
As mentioned, cue-induced cravings, or the urge or desire to smoke in response to the
presentation of stimuli associated with smoking, has been implicated in the maintenance and
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persistence of nicotine use (Perkins, 2009). Theoretically, it is believed that greater magnitudes
of cue-induced craving predict increased risk of relapse when faced with smoking-associated
stimuli in the natural environment given the strong likelihood that such stimuli become
associated with smoking and acquire incentive motivational properties. Given that urges and
cravings can be theorized as subjective emotional states responsible for continued drug use and
the inception of relapse (Carver & White, 1994), we aimed to discriminate the effects of drug
using behavior resulting from changes in subjective motivational states on CPP using both the
BIS/BAS and the QSU. While we saw no effects of the BAS Reward Responsiveness or Fun
Seeking subscales on CPP or differences between treatments, we did note that nicotine-treated
participants scored significantly higher on the BAS Drive subscale than did placebo-treated
participants. The BAS is said to motivate goal-driven behavior toward positively-reinforcing
cues. The Drive subscale assesses behavioral responding, while the Reward Responsiveness
scale evaluates affective responding, and the Fun Seeking scale measures both affective and
behavioral responding. Therefore, given our results, it is possible that nicotine users with low
levels of nicotine dependence have greater levels of behavioral responding for positivelyreinforcing stimuli, which might increase their likelihood of rating the reward-paired room more
favorably; however, it is important in future studies to investigate whether people with higher
dependence would score differently on other BIS/BAS measures.
Using the QSU, we also found that nicotine-treated participants who scored in the upper
50% on the Urge to Smoke subscale of the Questionnaire on Smoking Urges rated the M&Mpaired room as significantly more enjoyable compared to placebo-treated participants. Therefore,
nicotine reward enhancement was evident in nicotine-treated participants who indicated that their
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desire and intention to smoke was reward-seeking based, as opposed to smoking to relieve
negative affect and nicotine withdrawal.
Interestingly, using our QSU and BIS/BAS measures, we saw no influence of regulating
aversive motives on the acquisition of CPP. Scores on the BIS did not affect CPP regardless of
the degree of scoring on this scale, nor were there significant differences between treatment
groups in response to this measure. Additionally, responses on the Relief of Negative Affect
subscale of the QSU had no significant effect on CPP in terms of time or ratings, and did not
differ by treatment. Negative affect is typically described as a factor of nicotine withdrawal that
significantly predicts relapse with the expectation that nicotine use will attenuate negative mood
symptoms. Both the Relief of Negative Affect subscale and the BIS are thought to control the
experience of anxiety and to inhibit behavior that might produce negative or painful outcomes.
Therefore, sensitivity to these scales would reflect an individual’s propensity toward anxiety
when provided with the appropriate cues, and heightened avoidance of such anxiety-inducing
experiences. Pang et al. (2014) investigated the effects of negative affect and anxiety symptoms
as moderators of nicotine dependence severity, and found a positive relationship between
increasing levels of negative affect and anxiety symptoms and associations between smoking
expectancies and nicotine dependence severity. Given that we saw no relation of negative
reinforcement and CPP, it is possible that (1) the required 6-hour window of nicotine abstinence
prior to participating in our study was not long enough to manifest negative mood states strong
enough to elicit negative reinforcement, or (2) negative reinforcement plays a greater role for
individuals with higher levels of nicotine dependence that were not represented by our sample.
As mentioned, it has been suggested that since BAS responding reflects motivated goaldriven behavior toward positively-reinforcing cues, it may represent the biological underpinnings
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of impulsivity (Carver & White, 1994). Franken and Muris (2006) used the BIS/BAS
questionnaire to examine the influence of impulsivity on drug and alcohol use in college
students. Their results indicated that students’ drug and alcohol use was positively correlated
with BAS personality characteristics with the most substantial correlations found between the
BAS Fun Seeking and BAS Drive subscales. Given that nicotine-treated participants scored
significantly higher on the BAS Drive subscale than did placebo-treated participants in our study,
our findings also demonstrate a relationship between substance use and impulsivity.
Another measure often used to assess levels of impulsivity, the Kirby questionnaire
requires an individual to choose between immediate, but smaller theoretical monetary rewards
and delayed, but larger rewards. High levels of impulsivity also seem to contribute to nicotineenhanced CPP. A significant difference between treatment groups was found for participants
who scored in the upper 50% on the Kirby Monetary Choice Questionnaire, where nicotinetreated participants who scored highly on the Kirby questionnaire spent more time in the
previously-paired M&M room. Diergaarde and colleagues (2008) showed that impulsive choices
were associated with enhanced motivation to initiate and maintain nicotine self-administration.
Furthermore, impulsivity predicted a weakened ability to inhibit nicotine seeking during
abstinence, and an enhanced vulnerability to relapse upon re-exposure to nicotine cues.
Therefore, our findings complement those previously-published suggesting that nicotinemediated learning is influenced by high levels of impulsivity, and that interventions aimed to
improve impulse control might aid in the reduction of susceptibility to nicotine dependence
and/or lead to successful smoking cessation. Additionally, due to its sensitivity in detecting
appetitive responding for those who score highly on the Kirby and BAS-Drive questionnaires,
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utilizing the virtual CPP task seems advantageous in detecting underlying impulsivity traits
which may predict susceptibility to cue-induced cravings and higher rates of relapse.
While significant enhancement by nicotine on the acquisition of CPP in nicotinedependent users was noted, we did observe a lack of significant CPP in non-dependent nicotinetreated participants. As described previously, numerous studies emphasize the inherently
rewarding nature of nicotine as evidenced by increased self-administration behavior
(Henningfield et al., 1983; LeFoll & Goldberg, 2009) and by nicotine’s ability to produce CPP
(Fudala et al., 1985; Iwamoto, 1990; LeFoll & Goldberg, 2004). However, CPP results using
nicotine have been equivocal. It has been suggested that nicotine only produces CPP within a
relatively narrow dose range with the exact range determined by the influence of other
experimental parameters. Le Foll & Goldberg (2005) tested nicotine across a range of doses in
rodents and found CPP at 0.1, 0.4, 1 and 1.4 mg/kg sc, but not at 0.01, 0.04 and 2 mg/kg sc. In
the latter group of rats, 2 mg/kg sc nicotine produced a small but significant conditioned place
aversion (CPA) where animals displayed a preference for the non-nicotine-associated
environment. Numerous studies have reproduced investigations of dose-sensitive nicotine CPP
with discrepant results across studies where nicotine has been shown to produce no effect, a
CPP, or a CPA (Agatsuma et al., 2006; Spina et al., 2006; Laviolette & van der Kooy, 2003)
alluding to the complexity of nicotine’s effects on conditioning, and suggesting that nicotine can
produce both rewarding and aversive effects. Therefore, it may be the case that non-dependent
users are more sensitive to the aversive effects of nicotine treatment, thus accounting for the lack
of a significant CPP in non-dependent, nicotine-treated participants.
The two main objectives for Day 2 of the present study aimed to determine the
relationship between nicotine-treatment on extinction of CPP and reinstatement of the
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extinguished behavior. It was hypothesized that if nicotine increased the reinforcing value of
non-drug rewards, then this should result in a preference for the reward-paired context that is
more resistant to extinction. However, we found no significant differences in time nor ratings
between Day 2 treatments for the first or second extinction sessions when examining nicotinedependent individuals who demonstrated a conditioned place preference on Day 1 (Fagerstrom >
0; CPP Difference Score >0). Interestingly, we did observe a CPP by the third extinction session
such that individuals who received nicotine on Day 1 and placebo on Day 2 spent significantly
more time in the M&M-paired room than placebo-treated participants.
Existing literature illustrates a complex relationship between nicotine and extinction.
While some studies demonstrate that nicotine delays extinction of conditioned responses in that
animals continue to respond for previously-rewarded stimuli that are no longer enforced (Clark
et al., 2001), other studies found that the effects of nicotine on extinction can vary, and are
dependent upon experiment parameters (Elias et al., 2010; Brenhouse & Andersen, 2008). As
mentioned previously, Elias and colleagues (2010) demonstrated that the effects of nicotine on
the extinction of fear conditioning were contingent upon when nicotine was administered and on
the context during extinction. Nicotine facilitated extinction when administered only at
extinction; however nicotine delayed extinction when administered at both training and
extinction. Furthermore, this delay of extinction was dependent on the consistency of contextual
information between training and extinction. Nicotine administered at both training and
extinction delayed extinction only if the context was the same at both stages, but if the context
changed between training and extinction, no effect of nicotine was seen. Furthermore, Raiff and
Dallery (2008) showed that nicotine increased responding maintained by conditioned reinforcers,
but did not increase resistance to extinction on any of the response types studied.
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While one explanation for our results is that we are in fact seeing delayed extinction
during the third extinction session as an effect of Day 1 nicotine and Day 2 placebo-treatment, an
alternate explanation is that CPP elicited during the third extinction session, following the
extinction of CPP seen in extinction sessions one and two, actually reflect spontaneous recovery.
Spontaneous recovery is the return of a conditioned response elicited by a conditioned stimulus
when time passes following extinction (Brooks & Bouton, 1993). In a study by Cohen and
colleagues (2005), rats were allowed to self-administer nicotine in a specific environment, the
behavior was extinguished in the same environment, animals were withheld from that
environment for a certain time, and then behavior was recorded when animals were returned to
the drug-taking environment. The results from the study showed that the nicotine-associated
environmental cue effectively elicited recovery of nicotine-seeking responding after 25 days of
abstinence from the drug and environment in rats. A study by Troisi (2003) found no evidence
for spontaneous recovery two weeks following extinction, but partial recovery four weeks
following the final extinction phase, while Shaham et al. (1997) found spontaneous recovery of
the previously extinguished behavior when rats that had been housed for 21 days without being
exposed to the drug-taking environment were then re-exposed to that environment. Literature
concerning the timeline of spontaneous recovery following extinction is largely limited to nonhuman studies; however, these results suggest that spontaneous recovery is time-dependent
(Bouton, 1988) and that it may take several weeks following extinction before the return of a
conditioned response. Therefore, while we do see the return of conditioned behavior following
extinction, the theory of spontaneous recovery is not fully supported in that each of our three
extinction sessions is only 3-minutes long. This suggests that our participants have extinguished
a CPP and recovered the conditioned behavior in an unreasonably short timeframe. Some have
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coined this phenomenon “reacquisition” of a conditioned response post-extinction, which has
been described as occurring faster than the initial acquisition. Reacquisition may indicate that the
original learning was not destroyed but rather was “saved,” through the process of extinction
(Bouton, 2004). Given these observations, it is important in future work to dissociate the effects
of spontaneous recovery, reacquisition, and nicotine-induced resistance to extinction.
Finally, in examining the effect of nicotine on reinstatement we found that participants
who received nicotine on Day 2 reinstated by a significantly greater change between the amount
of time spent in the M&M-paired room during the third extinction session and the reinstatement
session compared to placebo-treated participants. Reinstatement refers to the recovery of
conditioned behavior produced by exposure to the unconditioned stimulus alone following
extinction. In the traditional reinstatement model, the effect of non-contingent re-exposure to
drugs on the reinstatement of drug-seeking is examined after training for self-administration of
drugs and subsequent extinction of the drug-reinforced behavior (Stewart & de Wit, 1987).
Using this procedure, investigators have shown that priming injections of nicotine reinstate
extinguished nicotine-taking behavior (Chiamulera et al. 1996; Shaham et al., 1997). In an effort
to expand upon this literature, we found that nicotine seems to promote the reinstatement of an
extinguished CPP for a food reward after priming by several M&M’s in a novel, neutral virtual
room. While our findings deviate somewhat from the traditional reinstatement model in that
reward-priming after nicotine-treatment increased the magnitude of CPP after the third extinction
session without inducing a significant CPP, we do feel confident that the results suggest that
nicotine promotes reinstatement for conditioned behavior.
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Future Directions
The current study has provided us with novel and informative data in understanding the
role of nicotine in enhancing conditioned place preferences in humans using a virtual task.
Furthermore, these data provide a foundation for future studies aimed at more thoroughly
characterizing the reward mechanisms that underlie risks for maintaining nicotine use, as well as
risks for relapse following cessation.
Given that our lab has previously demonstrated much stronger CPPs in terms of time and
ratings in undergraduate participants using 6-minute conditioning sessions (Astur et al., 2014),
future studies will return to the 6-minute paradigm from the current 3-minute paradigm, in hopes
of examining nicotine enhancing effects on CPP in terms of both time and ratings with a more
powerful pairing paradigm. Additionally, after establishing a relationship between nicotine
dependence and CPP, it is of interest to examine the effects of dependence severity on our
behavioral measures. A majority of participants in our sample reported low levels of nicotine
dependence (Fagerstrom score average = 1); therefore, future work should investigate whether
individuals with increased dependence condition more strongly or have greater resistance to
extinction, particularly because dependence indices have been shown to predict cue-induced
cravings and subsequent relapse.
Expecting to find an effect of negatively-reinforcing motivational states on our
behavioral measures, particularly given previous literature which agrees that a major
motivational basis of drug dependence is the reduction or avoidance of aversive internal states
(Baker et al., 2004), it was surprising to find that negative reinforcement did not affect the
acquisition of CPP using the BIS or the QSU-Relief of Negative Affect scales, especially for
those who received nicotine treatment. While lengthening the required 6-hour window of
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nicotine abstinence prior to participating in our study may be necessary to manifest negative
mood states strong enough to elicit negative reinforcement, it would also be interesting to
examine the effects of nicotine on a Pavlovian aversive task, like the conditioned place aversion
(CPA) task. Traditionally, the CPA paradigm involves repeatedly pairing an aversive
unconditioned stimulus (i.e. an electrical shock) with a particular neutral context (conditioned
stimulus, CS). These repeated pairings eventually result in a learned association between the CS
and the aversive US, such that participants express a fearful conditioned response (CR) to the
originally neutral conditioned stimulus. This unpleasant emotional reaction would then serve to
negatively reinforce a response that terminates the CS, and thus terminates the conditioned
response. In theory, when given unrestricted access to two contexts, one previously-paired with
the US and the other neutral, participants should demonstrate a strong aversion for the room in
which the shock was previously paired despite the shock no longer being present. Furthermore,
nicotine administration prior to acquisition of the conditioned response should enhance a CPA.
Given the complexity of our Day 2 results, future research should further explore the
effects of nicotine on extinction, but also attempt to better discriminate these results from
spontaneous recovery and reacquisition. Currently we employ three 3-minute extinction sessions
to assess whether nicotine delays extinction. Going forward, it may be best to use one longer
extinction session and examine behavior throughout that session. Examining nicotine’s effects on
extinction after 1, 3, or 7 day delays might also be insightful in investigating whether longer
acquisition-extinction intervals are more or less prone to spontaneous recovery.
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Conclusions
Overall, the current body of work has provided a solid foundation for future work
describing the effects of nicotine on conditioning, extinction, and reinstatement. Collectively, our
results demonstrate that nicotine (1) enhances reward sensitivity of non-nicotine rewards, (2)
slows extinction, and (3) promotes reinstatement. Additionally, our study demonstrates the
efficacy of utilizing the virtual conditioned place preference paradigm in understanding the
behavioral mechanisms by which nicotine enhances responding for conditioned rewards.
Importantly, the current findings of our study, as well as those we have proposed, will allow for
better understanding and interpretation of future studies with regard to mechanisms of nicotine
dependence, and provide insight into how nicotine can be particularly resistant to treatment.
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Figures

Figure 1A. Both rooms were identical in shape and size, but contained different items, colors
and patterns.

Figure 1B. A sample testing order for one participant on Day 1 and Day 2. Across participants,
testing order and M&M/Room pairings was counterbalanced.
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Figure 2A. Day 1 placebo group spends significantly more time in the previously-paired M&M
room during the test session compared to the No M&M Room (t(38) = 1.99, p < 0.05). No
significant difference in time for nicotine-treated participants (t(33) = 0.67, p = 0.51).

Differences Between Treatment Groups in Time
and Ratings During Day 1 Test Session
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Figure 2B. No significant differences between treatment groups in the amount of time spent in
M&M room on test day (F(1,72) = 0.25, p = 0.62), nor in ratings of the M&M-paired room on
test day (F(1,72) = 0.64, p = 0.43).
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Figure 3. Day 1 nicotine group rates previously-paired M&M room more favorably than does
placebo group when Fagerstrom score greater than zero (F(1, 35) = 4.72, p < 0.05).
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Figure 4. Participants who receive nicotine on Day 1 spend more time in previously-paired
M&M room than placebo group during third extinction session (F(1, 18) = 13.7, p < 0.05).
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Figure 5. Participants who receive placebo on Day 2 spend more time in previously-paired
M&M room than nicotine group during third extinction session (F(1, 18) = 5.01, p < 0.05).
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Figure 6. Effects of Day 1 and Day 2 treatments where nicotine on Day 1 and placebo on Day 2
are most likely to result in a conditioned place preference during extinction.
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Figure 7. Day 2 nicotine-treated participants reinstate by a significantly greater change between
the amount of time spent in the M&M-paired room during the third extinction session and the
reinstatement session (F(1, 18) = 5.87, p < 0.05).
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